骨密度計の市場:タイプ(DEXA、Peripheral)、アプリケーション(骨減少症・骨粗鬆症、嚢胞性線維症、CKD、体組成測定、関節リウマチ)、エンドユーザー(病院・専門クリニック、診断センター)別 - 2027年までの世界市場予測Bone Densitometer Market by Type (DEXA, Peripheral), Application (Osteopenia & Osteoporosis, Cystic Fibrosis, CKD, Body Composition Measurement, Rheumatoid Arthritis), End User (Hospitals & Specialty Clinics, Diagnostic Centres) - Global Forecast to 2027 骨密度計は、骨に含まれるカルシウムなどのミネラルの量を測定するための装置です。主に骨密度低下症や骨粗鬆症といった骨密度が低い疾患の検出に使用されます。骨密度計の世界市場は、2022年の2億900万ドルから2... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー骨密度計は、骨に含まれるカルシウムなどのミネラルの量を測定するための装置です。主に骨密度低下症や骨粗鬆症といった骨密度が低い疾患の検出に使用されます。骨密度計の世界市場は、2022年の2億900万ドルから2027年には3億7800万ドルに達すると予測され、予測期間中のCAGRは4.7%となります。"骨密度計市場は、軸骨密度計セグメントが最大シェアを占める見込み" 軸状骨密度測定器は、臨床医の様々な要求を満たすものであり、これが市場成長の主な要因となっています。これらの機器は、主に診断手順で正確な結果を得るために不可欠な中央二重エネルギーX線吸収法ベースのツールを含んでいます。 "骨粗鬆症・骨減少症診断セグメントが骨密度計市場で最大のシェアを占める見込み" 2021年の世界の骨密度計市場では、骨粗鬆症&骨減少症診断セグメントが最大のシェアを占めています。骨粗鬆症を患う老年人口が多いこと、更年期女性における骨粗鬆症のリスクが高まっていることが、セグメントの成長を促進する主な要因となっています。 "病院&専門クリニックセグメントが骨密度計市場で最大シェアを占める見込み" 2021年の世界の骨密度計市場では、病院&専門クリニックセグメントが最大のシェアを占めています。病院は高価な機器を購入する経済力があり、骨密度計を効果的に使用できる訓練を受けた専門家がいます。また、専門クリニックでは、骨粗鬆症や骨減少症などの様々な病状の診断や、体格測定に骨密度計を使用しています。 "予測期間中に最も高い成長を遂げるのはアジア太平洋地域市場" APAC市場は、予測期間中に最も高いCAGRで成長すると推定されます。アジア諸国(特に中国とインド)は、主に老年人口の増加、骨粗鬆症の発生率の増加、医療費の増加、それぞれの医療制度における病院や診療所の数の増加により、予測期間中に市場参加者に大きな成長機会を提供すると予想されます。 本レポートで参照した骨密度計市場の主な参加企業の内訳は以下の通りです。 - 企業タイプ別Tier 1~33%、Tier 2~45%、Tier 3~22%。 - 役職別Cレベル-31%、ディレクターレベル-37%、その他-22 - 地域別北米-35%、欧州-30%、アジア太平洋-15%、中南米-10%、中東・アフリカ-10 骨密度計市場の有力企業には、GEヘルスケア(米国)、ホロジック社(米国)、OSIシステムズ社(米国)、ダイアグノスティック・メディカル・システムズ・グループ(フランス)、スイスレイ・グローバル・ヘルスケア・ホールディングス社(台湾)、ビームメド社(米国)などがあります。(台湾)、BeamMed, Ltd. (イスラエル)、Echolight, Inc.(イスラエル)、Echolight S.P.A(イタリア)、Scanflex Healthcare AB(スウェーデン)、Medonica Co.(韓国)、Eurotec Systems S.r.l(イタリア)、AMPall Co.(韓国)、L'acn L'accessorio Nucleare S.R.L(イタリア)、 Shenzhen XRAY Electric Co.(中国)、YOZMA BMTech Co.(韓国)、Nanoomtech Co.(韓国)、Osteosys Corporation (韓国)、古野電気株式会社(日本)(日本)、襄陽カンロタデジタル超音波システム有限公司(中国)、新高雄デジタル超音波システム有限公司(中国)。(中国)、XinGaoYi Co.(中国)、安陪医療器材(中国)、広州医星龍医療器材有限公司(中国)(中国)、Trivitron Healthcare(インド)、OsCare Medical Oy(フィンランド)、CyberLogic, Inc.(米国)、Nanjing Kejin Industrial Co.(Ltd.(中国)。 調査対象 本レポートでは、各種骨密度計の市場やその採用パターンを分析しています。世界の骨密度計市場と技術、アプリケーション、エンドユーザー、地域などの異なるセグメントの市場規模や今後の成長可能性を推定することを目的としています。また、同市場の主要企業の企業概要、製品・サービス内容、最近の開発状況などとともに、詳細な競合分析も掲載しています。 本レポートを購入する理由 本レポートは、既存企業だけでなく、新規参入企業や中小企業も市場の脈拍を測ることができ、ひいてはより大きなシェアを獲得するのに役立つでしょう。本レポートを購入された企業は、以下の5つの戦略を組み合わせることで、市場での存在感を高めることができます。 本レポートでは、以下のポイントについて考察しています。 - 市場浸透。骨密度計の世界市場でトップ企業が提供する製品ポートフォリオに関する包括的な情報 - 製品開発/イノベーション。骨密度計の世界市場における今後の動向、研究開発活動、製品・サービスの発売に関する詳細な洞察 - 市場開発。タイプ、アプリケーション、エンドユーザー、地域ごとの有利な新興地域に関する包括的な情報 - 市場の多様化。骨密度計の世界市場における新製品、成長地域、最近の開発に関する徹底的な情報。 - 競争力の評価。骨密度計の世界市場における主要企業の市場シェア、成長戦略、収益分析、製品・サービスに関する詳細な評価。 目次1 INTRODUCTION 241.1 OBJECTIVES OF THE STUDY 24 1.2 MARKET DEFINITION 24 1.2.1 MARKETS COVERED 25 1.2.2 YEARS CONSIDERED 25 1.3 CURRENCY 26 1.4 LIMITATIONS 26 1.5 STAKEHOLDERS 26 1.6 SUMMARY OF CHANGES 26 2 RESEARCH METHODOLOGY 27 2.1 RESEARCH DATA 27 FIGURE 1 RESEARCH DESIGN 27 2.1.1 SECONDARY DATA 27 2.1.1.1 Key data from secondary sources 28 2.1.2 PRIMARY DATA 28 FIGURE 2 PRIMARY SOURCES 28 2.1.2.1 Key data from primary sources 29 2.1.2.2 Breakdown of primary sources 30 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30 2.2 MARKET SIZE ESTIMATION 30 FIGURE 4 BOTTOM-UP APPROACH 30 FIGURE 5 TOP-DOWN APPROACH 31 FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2021) 31 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32 FIGURE 7 DATA TRIANGULATION METHODOLOGY 32 2.4 MARKET SHARE ESTIMATION 33 2.5 ASSUMPTIONS 33 3 EXECUTIVE SUMMARY 34 FIGURE 8 BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 34 FIGURE 9 BONE DENSITOMETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 35 FIGURE 10 BONE DENSITOMETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 35 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE BONE DENSITOMETERS MARKET 36 4 PREMIUM INSIGHTS 37 4.1 BONE DENSITOMETERS MARKET OVERVIEW 37 FIGURE 12 INCREASING PREVALENCE OF OSTEOPOROSIS TO DRIVE THE MARKET FOR BONE DENSITOMETERS 37 4.2 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION AND COUNTRY (2021) 38 FIGURE 13 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS SEGMENT DOMINATED THE ASIA PACIFIC BONE DENSITOMETERS MARKET IN 2021 38 4.3 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39 FIGURE 14 CHINA TO WITNESS THE HIGHEST GROWTH IN THE BONE DENSITOMETERS MARKET FROM 2022 TO 2027 39 4.4 REGIONAL MIX: BONE DENSITOMETERS MARKET (2022–2027) 40 FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2022–2027) 40 4.5 BONE DENSITOMETERS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 40 FIGURE 16 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 40 5 MARKET OVERVIEW 41 5.1 INTRODUCTION 41 FIGURE 17 BONE DENSITOMETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41 5.2 MARKET DRIVERS 42 5.2.1 RISING INCIDENCE OF OSTEOPOROSIS 42 5.2.2 GROWING GERIATRIC POPULATION 42 5.2.3 RISING PREVALENCE OF KIDNEY DISEASE 42 5.3 MARKET RESTRAINTS 43 5.3.1 HIGH COST OF BONE DENSITOMETERS 43 5.4 MARKET OPPORTUNITIES 43 5.4.1 GROWTH OPPORTUNITIES IN EMERGING MARKETS 43 TABLE 1 EMERGING COUNTRIES: HEALTHCARE EXPENDITURE (% OF GDP), 2015 VS. 2019 43 5.5 MARKET CHALLENGES 44 5.5.1 LACK OF ACCESS TO DIAGNOSTICS 44 5.5.2 UNFAVORABLE REIMBURSEMENT SCENARIO 44 5.5.3 HOSPITAL BUDGET CUTS 44 5.6 ASSESSMENT OF COVID-19 IMPACT ON THE ECONOMIC SCENARIO OF THE BONE DENSITOMETERS MARKET 45 6 BONE DENSITOMETERS MARKET, BY TECHNOLOGY 46 6.1 INTRODUCTION 47 TABLE 2 BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 47 6.2 AXIAL BONE DENSITOMETRY 47 TABLE 3 AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 47 TABLE 4 AXIAL BONE DENSITOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 48 6.2.1 DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA) 48 6.2.1.1 Several advantages of DEXA scanners to drive growth in this market segment 48 TABLE 5 DUAL-ENERGY X-RAY ABSORPTIOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49 6.2.2 QUANTITATIVE COMPUTED TOMOGRAPHY (QCT) 49 6.2.2.1 Several drawbacks of QCT scanners, including relatively high radiation exposure and a higher precision error than that of DEXA, to limit market growth 49 TABLE 6 QUANTITATIVE COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50 6.3 PERIPHERAL BONE DENSITOMETRY 50 TABLE 7 PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 51 TABLE 8 PERIPHERAL BONE DENSITOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51 6.3.1 QUANTITATIVE ULTRASOUND (QUS) 52 6.3.1.1 Quantitative ultrasound scanners offer advantages such as low exposure to radiation and non-invasive measurement—key factors driving market growth 52 TABLE 9 QUANTITATIVE ULTRASOUND MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 52 6.3.2 RADIOGRAPHIC ABSORPTIOMETRY (RA) 53 6.3.2.1 Technical limitations associated with RA devices to limit market growth 53 TABLE 10 RADIOGRAPHIC ABSORPTIOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 53 6.3.3 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES 54 TABLE 11 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54 7 BONE DENSITOMETERS MARKET, BY APPLICATION 55 7.1 INTRODUCTION 56 TABLE 12 BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56 7.2 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS 56 7.2.1 LARGE GERIATRIC POPULATION SUFFERING FROM OSTEOPOROSIS AND INCREASING RISK OF OSTEOPOROSIS IN MENOPAUSAL WOMEN—KEY FACTORS DRIVING GROWTH 56 TABLE 13 BONE DENSITOMETERS MARKET FOR OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 57 7.3 CYSTIC FIBROSIS DIAGNOSIS 57 7.3.1 GROWING PREVALENCE OF CYSTIC FIBROSIS AND SUBSEQUENT INCREASE IN CASES OF OSTEOPOROSIS & OSTEOPENIA TO DRIVE THE DEMAND FOR BONE DENSITY TESTS 57 TABLE 14 BONE DENSITOMETERS MARKET FOR CYSTIC FIBROSIS DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 58 7.4 CHRONIC KIDNEY DISEASE DIAGNOSIS 58 7.4.1 GROWING PREVALENCE OF CHRONIC KIDNEY DISEASES TO INCREASE THE DEMAND FOR BONE DENSITOMETRY TESTS 58 TABLE 15 BONE DENSITOMETERS MARKET FOR CHRONIC KIDNEY DISEASE DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 59 7.5 BODY COMPOSITION MEASUREMENT 59 7.5.1 GROWING FOCUS ON ATHLETE PERFORMANCE TO SUPPORT MARKET GROWTH 59 TABLE 16 BONE DENSITOMETERS MARKET FOR BODY COMPOSITION MEASUREMENT, BY COUNTRY, 2020–2027 (USD MILLION) 60 7.6 RHEUMATOID ARTHRITIS DIAGNOSIS 60 7.6.1 HIGH RISK OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES ASSOCIATED WITH RHEUMATOID ARTHRITIS TO FUEL THE NEED FOR BONE DENSITOMETERS 60 TABLE 17 BONE DENSITOMETERS MARKET FOR RHEUMATOID ARTHRITIS DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 61 8 BONE DENSITOMETERS MARKET, BY END USER 62 8.1 INTRODUCTION 63 TABLE 18 BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 63 8.2 HOSPITALS & SPECIALTY CLINICS 63 8.2.1 HIGH PURCHASING CAPACITY OF HOSPITALS COMPARED TO DIAGNOSTIC AND AMBULATORY CENTERS TO DRIVE THE ADOPTION OF HIGH-COST DEXA SCANNERS AMONG HOSPITALS 63 TABLE 19 BONE DENSITOMETERS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 64 8.3 DIAGNOSTIC & IMAGING CENTERS 64 8.3.1 HIGH COST OF BONE DENSITOMETERS AND CONTINUOUS REIMBURSEMENT CUTS IN OUTPATIENT DIAGNOSTIC IMAGING TO LIMIT GROWTH IN THIS END-USER SEGMENT 64 TABLE 20 BONE DENSITOMETERS MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 65 8.4 OTHER END USERS 65 TABLE 21 BONE DENSITOMETERS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 66 9 BONE DENSITOMETERS MARKET, BY REGION 67 9.1 INTRODUCTION 68 FIGURE 18 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68 TABLE 22 BONE DENSITOMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 68 TABLE 23 BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69 9.2 NORTH AMERICA 69 FIGURE 19 NORTH AMERICA: BONE DENSITOMETERS MARKET SNAPSHOT 70 TABLE 24 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71 TABLE 25 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71 TABLE 26 NORTH AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 71 TABLE 27 NORTH AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 72 TABLE 28 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72 TABLE 29 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 72 9.2.1 US 73 9.2.1.1 Favorable reimbursement scenario in the US to drive market growth 73 TABLE 30 US: KEY MACROINDICATORS 73 TABLE 31 US: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 74 TABLE 32 US: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 74 TABLE 33 US: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 74 TABLE 34 US: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75 TABLE 35 US: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 75 9.2.2 CANADA 75 9.2.2.1 Growing geriatric population in Canada to support market growth 75 TABLE 36 CANADA: KEY MACROINDICATORS 76 TABLE 37 CANADA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 76 TABLE 38 CANADA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 76 TABLE 39 CANADA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 77 TABLE 40 CANADA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77 TABLE 41 CANADA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 77 9.3 EUROPE 78 TABLE 42 EUROPE: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 43 EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78 TABLE 44 EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 79 TABLE 45 EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 79 TABLE 46 EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79 TABLE 47 EUROPE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80 9.3.1 GERMANY 80 9.3.1.1 Growing prevalence of osteoporosis in Germany to fuel the demand for bone densitometers in the country 80 TABLE 48 GERMANY: KEY MACROINDICATORS 80 TABLE 49 GERMANY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81 TABLE 50 GERMANY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 81 TABLE 51 GERMANY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 81 TABLE 52 GERMANY: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82 TABLE 53 GERMANY: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 82 9.3.2 FRANCE 82 9.3.2.1 Increasing healthcare expenditure in France to boost the adoption of bone densitometers 82 TABLE 54 FRANCE: KEY MACROINDICATORS 83 TABLE 55 FRANCE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83 TABLE 56 FRANCE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 83 TABLE 57 FRANCE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 84 TABLE 58 FRANCE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84 TABLE 59 FRANCE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 84 9.3.3 UK 85 9.3.3.1 Increasing number of fragility fracture cases to drive growth in the UK bone densitometers market 85 TABLE 60 UK: KEY MACROINDICATORS 85 TABLE 61 UK: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 85 TABLE 62 UK: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 86 TABLE 63 UK: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 86 TABLE 64 UK: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86 TABLE 65 UK: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87 9.3.4 ITALY 87 9.3.4.1 Large geriatric population in the country and subsequent increase in the prevalence of age-related chronic conditions to fuel growth in the market 87 TABLE 66 ITALY: KEY MACROINDICATORS 87 TABLE 67 ITALY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88 TABLE 68 ITALY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 88 TABLE 69 ITALY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 88 TABLE 70 ITALY: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89 TABLE 71 ITALY: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 89 9.3.5 SPAIN 89 9.3.5.1 Improved monitoring of fragility fractures and their management through national registries to propel the market for bone densitometers in Spain 89 TABLE 72 SPAIN: KEY MACROINDICATORS 90 TABLE 73 SPAIN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90 TABLE 74 SPAIN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 91 TABLE 75 SPAIN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 91 TABLE 76 SPAIN: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91 TABLE 77 SPAIN: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 92 9.3.6 REST OF EUROPE 92 TABLE 78 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92 TABLE 79 REST OF EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 92 TABLE 80 REST OF EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 93 TABLE 81 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93 TABLE 82 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 93 9.4 ASIA PACIFIC 94 FIGURE 20 ASIA PACIFIC: BONE DENSITOMETERS MARKET SNAPSHOT 94 TABLE 83 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95 TABLE 84 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 95 TABLE 85 ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 95 TABLE 86 ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 96 TABLE 87 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96 TABLE 88 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 96 9.4.1 JAPAN 97 9.4.1.1 Large geriatric population in Japan to fuel the demand for bone densitometers 97 TABLE 89 JAPAN: KEY MACROINDICATORS 97 TABLE 90 JAPAN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98 TABLE 91 JAPAN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 98 TABLE 92 JAPAN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 98 TABLE 93 JAPAN: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99 TABLE 94 JAPAN: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 99 9.4.2 CHINA 99 9.4.2.1 Increasing incidence of fractures due to osteoporosis to support market growth 99 TABLE 95 CHINA: KEY MACROINDICATORS 100 TABLE 96 CHINA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 100 TABLE 97 CHINA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 100 TABLE 98 CHINA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 101 TABLE 99 CHINA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101 TABLE 100 CHINA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 101 9.4.3 INDIA 102 9.4.3.1 Rising osteoporosis & osteoarthritis rates to support the demand for bone densitometers in India 102 TABLE 101 INDIA: KEY MACROINDICATORS 102 TABLE 102 INDIA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 102 TABLE 103 INDIA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 103 TABLE 104 INDIA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 103 TABLE 105 INDIA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103 TABLE 106 INDIA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104 9.4.4 REST OF ASIA PACIFIC 104 TABLE 107 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 104 TABLE 108 REST OF ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 104 TABLE 109 REST OF ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 105 TABLE 110 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105 TABLE 111 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 105 9.5 LATIN AMERICA 106 9.5.1 EFFORTS TO CLOSE THE CARE GAP AND INCREASE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH IN LATIN AMERICA 106 TABLE 112 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 106 TABLE 113 LATIN AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 107 TABLE 114 LATIN AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 107 TABLE 115 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107 TABLE 116 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 108 9.6 MIDDLE EAST & AFRICA 108 9.6.1 POLITICAL INSTABILITY IN THE MIDDLE EAST & AFRICA TO HINDER MARKET GROWTH 108 TABLE 117 MIDDLE EAST & NORTH AFRICA: NUMBER OF HIP FRACTURES, 2010 VS. 2020 108 TABLE 118 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 109 TABLE 119 MIDDLE EAST & AFRICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 109 TABLE 120 MIDDLE EAST & AFRICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 110 TABLE 121 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110 TABLE 122 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 110 10 COMPETITIVE LANDSCAPE 111 10.1 INTRODUCTION 111 10.2 COMPETITIVE LEADERSHIP MAPPING 111 10.2.1 STARS 111 10.2.2 EMERGING LEADERS 111 10.2.3 PERVASIVE PLAYERS 112 10.2.4 PARTICIPANTS 112 FIGURE 21 BONE DENSITOMETERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 112 10.3 BONE DENSITOMETERS MARKET: GEOGRAPHICAL ASSESSMENT 113 FIGURE 22 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BONE DENSITOMETERS MARKET (2021) 113 10.4 MARKET SHARE ANALYSIS 114 FIGURE 23 BONE DENSITOMETERS MARKET SHARE, BY KEY PLAYER, 2021 114 10.5 COMPETITIVE SITUATION AND TRENDS 115 10.5.1 DEALS (2019–2022) 115 10.5.2 OTHER DEVELOPMENTS (2021) 115 11 COMPANY PROFILES 116 11.1 KEY PLAYERS 116 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 11.1.1 GE HEALTHCARE 116 TABLE 123 GE HEALTHCARE: BUSINESS OVERVIEW 116 FIGURE 24 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 117 11.1.2 HOLOGIC, INC. 119 TABLE 124 HOLOGIC, INC.: BUSINESS OVERVIEW 119 FIGURE 25 HOLOGIC, INC.: COMPANY SNAPSHOT (2021) 120 11.1.3 OSI SYSTEMS, INC. 122 TABLE 125 OSI SYSTEMS, INC.: BUSINESS OVERVIEW 122 FIGURE 26 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 123 11.1.4 DIAGNOSTIC MEDICAL SYSTEMS GROUP 125 TABLE 126 DIAGNOSTIC MEDICAL SYSTEMS GROUP: BUSINESS OVERVIEW 125 11.1.5 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD. 126 TABLE 127 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD.: BUSINESS OVERVIEW 126 11.1.6 BEAMMED, LTD. 127 TABLE 128 BEAMMED, LTD.: BUSINESS OVERVIEW 127 11.1.7 ECHOLIGHT S.P.A 128 TABLE 129 ECHOLIGHT S.P.A.: BUSINESS OVERVIEW 128 11.1.8 SCANFLEX HEALTHCARE AB 129 TABLE 130 SCANFLEX HEALTHCARE AB: BUSINESS OVERVIEW 129 11.1.9 MEDONICA CO., LTD. 130 TABLE 131 MEDONICA CO., LTD.: BUSINESS OVERVIEW 130 11.1.10 EUROTEC MEDICAL SYSTEMS S.R.L. 131 TABLE 132 EUROTEC MEDICAL SYSTEMS S.R.L.: BUSINESS OVERVIEW 131 11.2 OTHER PLAYERS 132 11.2.1 AMPALL CO., LTD. 132 TABLE 133 AMPALL CO., LTD.: BUSINESS OVERVIEW 132 11.2.2 L’ACN L’ACCESSORIO NUCLEARE S.R.L 133 TABLE 134 L’ACN L’ACCESSORIO NUCLEARE S.R.L.: BUSINESS OVERVIEW 133 11.2.3 SHENZHEN XRAY ELECTRIC CO., LTD. 134 TABLE 135 SHENZHEN XRAY ELECTRIC CO., LTD.: BUSINESS OVERVIEW 134 11.2.4 YOZMA BMTECH CO., LTD. 135 TABLE 136 YOZMA BMTECH CO., LTD.: BUSINESS OVERVIEW 135 11.2.5 NANOOMTECH CO., LTD. 136 TABLE 137 NANOOMTECH CO., LTD.: BUSINESS OVERVIEW 136 11.2.6 OSTEOSYS CORPORATION 137 TABLE 138 OSTEOSYS CORPORATION: BUSINESS OVERVIEW 137 11.2.7 FURUNO ELECTRIC CO., LTD. 138 TABLE 139 FURUNO ELECTRIC CO., LTD.: BUSINESS OVERVIEW 138 11.2.8 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD. 139 TABLE 140 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD.: BUSINESS OVERVIEW 139 11.2.9 XINGAOYI CO., LTD. 140 TABLE 141 XINGAOYI CO., LTD.: BUSINESS OVERVIEW 140 11.2.10 ANJUE MEDICAL EQUIPMENT CO., LTD. 141 TABLE 142 ANJUE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 141 11.2.11 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD. 142 TABLE 143 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 142 11.2.12 TRIVITRON HEALTHCARE 143 TABLE 144 TRIVITRON HEALTHCARE: BUSINESS OVERVIEW 143 11.2.13 OSCARE MEDICAL OY 144 TABLE 145 OSCARE MEDICAL OY: BUSINESS OVERVIEW 144 11.2.14 CYBERLOGIC, INC. 145 TABLE 146 CYBERLOGIC, INC.: BUSINESS OVERVIEW 145 11.2.15 NANJING KEJIN INDUSTRIAL CO., LTD. 146 TABLE 147 NANJING KEJIN INDUSTRIAL CO., LTD.: BUSINESS OVERVIEW 146 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 12 APPENDIX 147 12.1 DISCUSSION GUIDE 147 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151 12.3 AVAILABLE CUSTOMIZATIONS 153 12.4 RELATED REPORTS 153 12.5 AUTHOR DETAILS 154
SummaryBone densitometers are used to measure the amount of calcium and other minerals in the bones. They are used primarily to detect osteopenia or osteoporosis, diseases in which the bone mineral density is low. The global bone densitometer market is projected to reach USD 378 million by 2027 from USD 299 million in 2022, at a CAGR of 4.7% during the forecast period. Table of Contents1 INTRODUCTION 241.1 OBJECTIVES OF THE STUDY 24 1.2 MARKET DEFINITION 24 1.2.1 MARKETS COVERED 25 1.2.2 YEARS CONSIDERED 25 1.3 CURRENCY 26 1.4 LIMITATIONS 26 1.5 STAKEHOLDERS 26 1.6 SUMMARY OF CHANGES 26 2 RESEARCH METHODOLOGY 27 2.1 RESEARCH DATA 27 FIGURE 1 RESEARCH DESIGN 27 2.1.1 SECONDARY DATA 27 2.1.1.1 Key data from secondary sources 28 2.1.2 PRIMARY DATA 28 FIGURE 2 PRIMARY SOURCES 28 2.1.2.1 Key data from primary sources 29 2.1.2.2 Breakdown of primary sources 30 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30 2.2 MARKET SIZE ESTIMATION 30 FIGURE 4 BOTTOM-UP APPROACH 30 FIGURE 5 TOP-DOWN APPROACH 31 FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2021) 31 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32 FIGURE 7 DATA TRIANGULATION METHODOLOGY 32 2.4 MARKET SHARE ESTIMATION 33 2.5 ASSUMPTIONS 33 3 EXECUTIVE SUMMARY 34 FIGURE 8 BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 34 FIGURE 9 BONE DENSITOMETERS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 35 FIGURE 10 BONE DENSITOMETERS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 35 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE BONE DENSITOMETERS MARKET 36 4 PREMIUM INSIGHTS 37 4.1 BONE DENSITOMETERS MARKET OVERVIEW 37 FIGURE 12 INCREASING PREVALENCE OF OSTEOPOROSIS TO DRIVE THE MARKET FOR BONE DENSITOMETERS 37 4.2 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION AND COUNTRY (2021) 38 FIGURE 13 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS SEGMENT DOMINATED THE ASIA PACIFIC BONE DENSITOMETERS MARKET IN 2021 38 4.3 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 39 FIGURE 14 CHINA TO WITNESS THE HIGHEST GROWTH IN THE BONE DENSITOMETERS MARKET FROM 2022 TO 2027 39 4.4 REGIONAL MIX: BONE DENSITOMETERS MARKET (2022–2027) 40 FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2022–2027) 40 4.5 BONE DENSITOMETERS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 40 FIGURE 16 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 40 5 MARKET OVERVIEW 41 5.1 INTRODUCTION 41 FIGURE 17 BONE DENSITOMETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41 5.2 MARKET DRIVERS 42 5.2.1 RISING INCIDENCE OF OSTEOPOROSIS 42 5.2.2 GROWING GERIATRIC POPULATION 42 5.2.3 RISING PREVALENCE OF KIDNEY DISEASE 42 5.3 MARKET RESTRAINTS 43 5.3.1 HIGH COST OF BONE DENSITOMETERS 43 5.4 MARKET OPPORTUNITIES 43 5.4.1 GROWTH OPPORTUNITIES IN EMERGING MARKETS 43 TABLE 1 EMERGING COUNTRIES: HEALTHCARE EXPENDITURE (% OF GDP), 2015 VS. 2019 43 5.5 MARKET CHALLENGES 44 5.5.1 LACK OF ACCESS TO DIAGNOSTICS 44 5.5.2 UNFAVORABLE REIMBURSEMENT SCENARIO 44 5.5.3 HOSPITAL BUDGET CUTS 44 5.6 ASSESSMENT OF COVID-19 IMPACT ON THE ECONOMIC SCENARIO OF THE BONE DENSITOMETERS MARKET 45 6 BONE DENSITOMETERS MARKET, BY TECHNOLOGY 46 6.1 INTRODUCTION 47 TABLE 2 BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 47 6.2 AXIAL BONE DENSITOMETRY 47 TABLE 3 AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 47 TABLE 4 AXIAL BONE DENSITOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 48 6.2.1 DUAL-ENERGY X-RAY ABSORPTIOMETRY (DEXA) 48 6.2.1.1 Several advantages of DEXA scanners to drive growth in this market segment 48 TABLE 5 DUAL-ENERGY X-RAY ABSORPTIOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 49 6.2.2 QUANTITATIVE COMPUTED TOMOGRAPHY (QCT) 49 6.2.2.1 Several drawbacks of QCT scanners, including relatively high radiation exposure and a higher precision error than that of DEXA, to limit market growth 49 TABLE 6 QUANTITATIVE COMPUTED TOMOGRAPHY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 50 6.3 PERIPHERAL BONE DENSITOMETRY 50 TABLE 7 PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 51 TABLE 8 PERIPHERAL BONE DENSITOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 51 6.3.1 QUANTITATIVE ULTRASOUND (QUS) 52 6.3.1.1 Quantitative ultrasound scanners offer advantages such as low exposure to radiation and non-invasive measurement—key factors driving market growth 52 TABLE 9 QUANTITATIVE ULTRASOUND MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 52 6.3.2 RADIOGRAPHIC ABSORPTIOMETRY (RA) 53 6.3.2.1 Technical limitations associated with RA devices to limit market growth 53 TABLE 10 RADIOGRAPHIC ABSORPTIOMETRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 53 6.3.3 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES 54 TABLE 11 OTHER PERIPHERAL BONE DENSITOMETRY TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 54 7 BONE DENSITOMETERS MARKET, BY APPLICATION 55 7.1 INTRODUCTION 56 TABLE 12 BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 56 7.2 OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS 56 7.2.1 LARGE GERIATRIC POPULATION SUFFERING FROM OSTEOPOROSIS AND INCREASING RISK OF OSTEOPOROSIS IN MENOPAUSAL WOMEN—KEY FACTORS DRIVING GROWTH 56 TABLE 13 BONE DENSITOMETERS MARKET FOR OSTEOPOROSIS & OSTEOPENIA DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 57 7.3 CYSTIC FIBROSIS DIAGNOSIS 57 7.3.1 GROWING PREVALENCE OF CYSTIC FIBROSIS AND SUBSEQUENT INCREASE IN CASES OF OSTEOPOROSIS & OSTEOPENIA TO DRIVE THE DEMAND FOR BONE DENSITY TESTS 57 TABLE 14 BONE DENSITOMETERS MARKET FOR CYSTIC FIBROSIS DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 58 7.4 CHRONIC KIDNEY DISEASE DIAGNOSIS 58 7.4.1 GROWING PREVALENCE OF CHRONIC KIDNEY DISEASES TO INCREASE THE DEMAND FOR BONE DENSITOMETRY TESTS 58 TABLE 15 BONE DENSITOMETERS MARKET FOR CHRONIC KIDNEY DISEASE DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 59 7.5 BODY COMPOSITION MEASUREMENT 59 7.5.1 GROWING FOCUS ON ATHLETE PERFORMANCE TO SUPPORT MARKET GROWTH 59 TABLE 16 BONE DENSITOMETERS MARKET FOR BODY COMPOSITION MEASUREMENT, BY COUNTRY, 2020–2027 (USD MILLION) 60 7.6 RHEUMATOID ARTHRITIS DIAGNOSIS 60 7.6.1 HIGH RISK OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES ASSOCIATED WITH RHEUMATOID ARTHRITIS TO FUEL THE NEED FOR BONE DENSITOMETERS 60 TABLE 17 BONE DENSITOMETERS MARKET FOR RHEUMATOID ARTHRITIS DIAGNOSIS, BY COUNTRY, 2020–2027 (USD MILLION) 61 8 BONE DENSITOMETERS MARKET, BY END USER 62 8.1 INTRODUCTION 63 TABLE 18 BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 63 8.2 HOSPITALS & SPECIALTY CLINICS 63 8.2.1 HIGH PURCHASING CAPACITY OF HOSPITALS COMPARED TO DIAGNOSTIC AND AMBULATORY CENTERS TO DRIVE THE ADOPTION OF HIGH-COST DEXA SCANNERS AMONG HOSPITALS 63 TABLE 19 BONE DENSITOMETERS MARKET FOR HOSPITALS & SPECIALTY CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 64 8.3 DIAGNOSTIC & IMAGING CENTERS 64 8.3.1 HIGH COST OF BONE DENSITOMETERS AND CONTINUOUS REIMBURSEMENT CUTS IN OUTPATIENT DIAGNOSTIC IMAGING TO LIMIT GROWTH IN THIS END-USER SEGMENT 64 TABLE 20 BONE DENSITOMETERS MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2020–2027 (USD MILLION) 65 8.4 OTHER END USERS 65 TABLE 21 BONE DENSITOMETERS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 66 9 BONE DENSITOMETERS MARKET, BY REGION 67 9.1 INTRODUCTION 68 FIGURE 18 BONE DENSITOMETERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68 TABLE 22 BONE DENSITOMETERS MARKET, BY REGION, 2020–2027 (USD MILLION) 68 TABLE 23 BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 69 9.2 NORTH AMERICA 69 FIGURE 19 NORTH AMERICA: BONE DENSITOMETERS MARKET SNAPSHOT 70 TABLE 24 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 71 TABLE 25 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 71 TABLE 26 NORTH AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 71 TABLE 27 NORTH AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 72 TABLE 28 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 72 TABLE 29 NORTH AMERICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 72 9.2.1 US 73 9.2.1.1 Favorable reimbursement scenario in the US to drive market growth 73 TABLE 30 US: KEY MACROINDICATORS 73 TABLE 31 US: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 74 TABLE 32 US: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 74 TABLE 33 US: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 74 TABLE 34 US: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 75 TABLE 35 US: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 75 9.2.2 CANADA 75 9.2.2.1 Growing geriatric population in Canada to support market growth 75 TABLE 36 CANADA: KEY MACROINDICATORS 76 TABLE 37 CANADA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 76 TABLE 38 CANADA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 76 TABLE 39 CANADA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 77 TABLE 40 CANADA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 77 TABLE 41 CANADA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 77 9.3 EUROPE 78 TABLE 42 EUROPE: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 78 TABLE 43 EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 78 TABLE 44 EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 79 TABLE 45 EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 79 TABLE 46 EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 79 TABLE 47 EUROPE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 80 9.3.1 GERMANY 80 9.3.1.1 Growing prevalence of osteoporosis in Germany to fuel the demand for bone densitometers in the country 80 TABLE 48 GERMANY: KEY MACROINDICATORS 80 TABLE 49 GERMANY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 81 TABLE 50 GERMANY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 81 TABLE 51 GERMANY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 81 TABLE 52 GERMANY: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 82 TABLE 53 GERMANY: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 82 9.3.2 FRANCE 82 9.3.2.1 Increasing healthcare expenditure in France to boost the adoption of bone densitometers 82 TABLE 54 FRANCE: KEY MACROINDICATORS 83 TABLE 55 FRANCE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 83 TABLE 56 FRANCE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 83 TABLE 57 FRANCE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 84 TABLE 58 FRANCE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 84 TABLE 59 FRANCE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 84 9.3.3 UK 85 9.3.3.1 Increasing number of fragility fracture cases to drive growth in the UK bone densitometers market 85 TABLE 60 UK: KEY MACROINDICATORS 85 TABLE 61 UK: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 85 TABLE 62 UK: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 86 TABLE 63 UK: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 86 TABLE 64 UK: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 86 TABLE 65 UK: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 87 9.3.4 ITALY 87 9.3.4.1 Large geriatric population in the country and subsequent increase in the prevalence of age-related chronic conditions to fuel growth in the market 87 TABLE 66 ITALY: KEY MACROINDICATORS 87 TABLE 67 ITALY: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 88 TABLE 68 ITALY: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 88 TABLE 69 ITALY: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 88 TABLE 70 ITALY: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 89 TABLE 71 ITALY: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 89 9.3.5 SPAIN 89 9.3.5.1 Improved monitoring of fragility fractures and their management through national registries to propel the market for bone densitometers in Spain 89 TABLE 72 SPAIN: KEY MACROINDICATORS 90 TABLE 73 SPAIN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 90 TABLE 74 SPAIN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 91 TABLE 75 SPAIN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 91 TABLE 76 SPAIN: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 91 TABLE 77 SPAIN: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 92 9.3.6 REST OF EUROPE 92 TABLE 78 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92 TABLE 79 REST OF EUROPE: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 92 TABLE 80 REST OF EUROPE: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 93 TABLE 81 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 93 TABLE 82 REST OF EUROPE: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 93 9.4 ASIA PACIFIC 94 FIGURE 20 ASIA PACIFIC: BONE DENSITOMETERS MARKET SNAPSHOT 94 TABLE 83 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95 TABLE 84 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 95 TABLE 85 ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 95 TABLE 86 ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 96 TABLE 87 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 96 TABLE 88 ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 96 9.4.1 JAPAN 97 9.4.1.1 Large geriatric population in Japan to fuel the demand for bone densitometers 97 TABLE 89 JAPAN: KEY MACROINDICATORS 97 TABLE 90 JAPAN: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 98 TABLE 91 JAPAN: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 98 TABLE 92 JAPAN: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 98 TABLE 93 JAPAN: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 99 TABLE 94 JAPAN: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 99 9.4.2 CHINA 99 9.4.2.1 Increasing incidence of fractures due to osteoporosis to support market growth 99 TABLE 95 CHINA: KEY MACROINDICATORS 100 TABLE 96 CHINA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 100 TABLE 97 CHINA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 100 TABLE 98 CHINA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 101 TABLE 99 CHINA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 101 TABLE 100 CHINA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 101 9.4.3 INDIA 102 9.4.3.1 Rising osteoporosis & osteoarthritis rates to support the demand for bone densitometers in India 102 TABLE 101 INDIA: KEY MACROINDICATORS 102 TABLE 102 INDIA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 102 TABLE 103 INDIA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 103 TABLE 104 INDIA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 103 TABLE 105 INDIA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 103 TABLE 106 INDIA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 104 9.4.4 REST OF ASIA PACIFIC 104 TABLE 107 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 104 TABLE 108 REST OF ASIA PACIFIC: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 104 TABLE 109 REST OF ASIA PACIFIC: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 105 TABLE 110 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 105 TABLE 111 REST OF ASIA PACIFIC: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 105 9.5 LATIN AMERICA 106 9.5.1 EFFORTS TO CLOSE THE CARE GAP AND INCREASE HEALTHCARE ACCESSIBILITY TO SUPPORT MARKET GROWTH IN LATIN AMERICA 106 TABLE 112 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 106 TABLE 113 LATIN AMERICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 107 TABLE 114 LATIN AMERICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 107 TABLE 115 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 107 TABLE 116 LATIN AMERICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 108 9.6 MIDDLE EAST & AFRICA 108 9.6.1 POLITICAL INSTABILITY IN THE MIDDLE EAST & AFRICA TO HINDER MARKET GROWTH 108 TABLE 117 MIDDLE EAST & NORTH AFRICA: NUMBER OF HIP FRACTURES, 2010 VS. 2020 108 TABLE 118 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 109 TABLE 119 MIDDLE EAST & AFRICA: AXIAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 109 TABLE 120 MIDDLE EAST & AFRICA: PERIPHERAL BONE DENSITOMETRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 110 TABLE 121 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 110 TABLE 122 MIDDLE EAST & AFRICA: BONE DENSITOMETERS MARKET, BY END USER, 2020–2027 (USD MILLION) 110 10 COMPETITIVE LANDSCAPE 111 10.1 INTRODUCTION 111 10.2 COMPETITIVE LEADERSHIP MAPPING 111 10.2.1 STARS 111 10.2.2 EMERGING LEADERS 111 10.2.3 PERVASIVE PLAYERS 112 10.2.4 PARTICIPANTS 112 FIGURE 21 BONE DENSITOMETERS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021 112 10.3 BONE DENSITOMETERS MARKET: GEOGRAPHICAL ASSESSMENT 113 FIGURE 22 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BONE DENSITOMETERS MARKET (2021) 113 10.4 MARKET SHARE ANALYSIS 114 FIGURE 23 BONE DENSITOMETERS MARKET SHARE, BY KEY PLAYER, 2021 114 10.5 COMPETITIVE SITUATION AND TRENDS 115 10.5.1 DEALS (2019–2022) 115 10.5.2 OTHER DEVELOPMENTS (2021) 115 11 COMPANY PROFILES 116 11.1 KEY PLAYERS 116 (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))* 11.1.1 GE HEALTHCARE 116 TABLE 123 GE HEALTHCARE: BUSINESS OVERVIEW 116 FIGURE 24 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 117 11.1.2 HOLOGIC, INC. 119 TABLE 124 HOLOGIC, INC.: BUSINESS OVERVIEW 119 FIGURE 25 HOLOGIC, INC.: COMPANY SNAPSHOT (2021) 120 11.1.3 OSI SYSTEMS, INC. 122 TABLE 125 OSI SYSTEMS, INC.: BUSINESS OVERVIEW 122 FIGURE 26 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2021) 123 11.1.4 DIAGNOSTIC MEDICAL SYSTEMS GROUP 125 TABLE 126 DIAGNOSTIC MEDICAL SYSTEMS GROUP: BUSINESS OVERVIEW 125 11.1.5 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD. 126 TABLE 127 SWISSRAY GLOBAL HEALTHCARE HOLDING, LTD.: BUSINESS OVERVIEW 126 11.1.6 BEAMMED, LTD. 127 TABLE 128 BEAMMED, LTD.: BUSINESS OVERVIEW 127 11.1.7 ECHOLIGHT S.P.A 128 TABLE 129 ECHOLIGHT S.P.A.: BUSINESS OVERVIEW 128 11.1.8 SCANFLEX HEALTHCARE AB 129 TABLE 130 SCANFLEX HEALTHCARE AB: BUSINESS OVERVIEW 129 11.1.9 MEDONICA CO., LTD. 130 TABLE 131 MEDONICA CO., LTD.: BUSINESS OVERVIEW 130 11.1.10 EUROTEC MEDICAL SYSTEMS S.R.L. 131 TABLE 132 EUROTEC MEDICAL SYSTEMS S.R.L.: BUSINESS OVERVIEW 131 11.2 OTHER PLAYERS 132 11.2.1 AMPALL CO., LTD. 132 TABLE 133 AMPALL CO., LTD.: BUSINESS OVERVIEW 132 11.2.2 L’ACN L’ACCESSORIO NUCLEARE S.R.L 133 TABLE 134 L’ACN L’ACCESSORIO NUCLEARE S.R.L.: BUSINESS OVERVIEW 133 11.2.3 SHENZHEN XRAY ELECTRIC CO., LTD. 134 TABLE 135 SHENZHEN XRAY ELECTRIC CO., LTD.: BUSINESS OVERVIEW 134 11.2.4 YOZMA BMTECH CO., LTD. 135 TABLE 136 YOZMA BMTECH CO., LTD.: BUSINESS OVERVIEW 135 11.2.5 NANOOMTECH CO., LTD. 136 TABLE 137 NANOOMTECH CO., LTD.: BUSINESS OVERVIEW 136 11.2.6 OSTEOSYS CORPORATION 137 TABLE 138 OSTEOSYS CORPORATION: BUSINESS OVERVIEW 137 11.2.7 FURUNO ELECTRIC CO., LTD. 138 TABLE 139 FURUNO ELECTRIC CO., LTD.: BUSINESS OVERVIEW 138 11.2.8 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD. 139 TABLE 140 XIANYANG KANROTA DIGITAL ULTRASOUND SYSTEM, CO., LTD.: BUSINESS OVERVIEW 139 11.2.9 XINGAOYI CO., LTD. 140 TABLE 141 XINGAOYI CO., LTD.: BUSINESS OVERVIEW 140 11.2.10 ANJUE MEDICAL EQUIPMENT CO., LTD. 141 TABLE 142 ANJUE MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 141 11.2.11 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD. 142 TABLE 143 GUANGZHOU MEDSINGLONG MEDICAL EQUIPMENT CO., LTD.: BUSINESS OVERVIEW 142 11.2.12 TRIVITRON HEALTHCARE 143 TABLE 144 TRIVITRON HEALTHCARE: BUSINESS OVERVIEW 143 11.2.13 OSCARE MEDICAL OY 144 TABLE 145 OSCARE MEDICAL OY: BUSINESS OVERVIEW 144 11.2.14 CYBERLOGIC, INC. 145 TABLE 146 CYBERLOGIC, INC.: BUSINESS OVERVIEW 145 11.2.15 NANJING KEJIN INDUSTRIAL CO., LTD. 146 TABLE 147 NANJING KEJIN INDUSTRIAL CO., LTD.: BUSINESS OVERVIEW 146 *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies. 12 APPENDIX 147 12.1 DISCUSSION GUIDE 147 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 151 12.3 AVAILABLE CUSTOMIZATIONS 153 12.4 RELATED REPORTS 153 12.5 AUTHOR DETAILS 154
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
MarketsandMarkets社のその他分野での最新刊レポート
本レポートと同じKEY WORD(cystic fibrosis)の最新刊レポートよくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|